Advanced Renal Pelvis Urothelial Carcinoma
1 clinical trials · Condition
◉ Watch Advanced Renal Pelvis Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958) | National Cancer Institute (NCI) | 2022-06-03 |
Track Advanced Renal Pelvis Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.